Meanwhile, high expression of HAVCR2 was significantly correlated with the poor prognosis of ovarian cancer (39), colon cancer (40), bladder urothelial carcinoma (41), and gastric cancer (42). The gene discussed is HAVCR2; the disease is bladder transitional cell carcinoma.